Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (BHU), Varanasi 221005, U.P., India.
Department of Microbiology, Institute of Medial Science, Banaras Hindu University, Varanasi 221005, U.P., India.
Int J Biol Macromol. 2023 Dec 31;253(Pt 5):127247. doi: 10.1016/j.ijbiomac.2023.127247. Epub 2023 Oct 5.
Staphylococcus aureus (S. aureus) and Pseudomonas aeruginosa (P. aeruginosa) bacteria are most commonly present in burn wound infections. Multidrug resistance (MDR) and biofilm formation make it difficult to treat these infections. Bacteriophages (BPs) are proven as an effective therapy against MDR as well as biofilm-associated wound infections. In the present work, a naturally inspired bacteriophage cocktail loaded chitosan microparticles-laden topical gel has been developed for the effective treatment of these infections. Bacteriophages against MDR S. aureus (BPSAФ1) and P. aeruginosa (BPPAФ1) were isolated and loaded separately and in combination into the chitosan microparticles (BPSAФ1-CHMPs, BPPAФ1-CHMPs, and MBP-CHMPs), which were later incorporated into the SEPINEO™ P 600 gel (BPSAФ1-CHMPs-gel, BPPAФ1-CHMPs-gel, and MBP-CHMPs-gel). BPs were characterized for their morphology, lytic activity, burst size, and hemocompatibility, and BPs belongs to Caudoviricetes class. Furthermore, BPSAФ1-CHMPs, BPPAФ1-CHMPs, and MBP-CHMPs had an average particle size of 1.19 ± 0.11, 1.42 ± 0.21, and 2.84 ± 0.28 μm, respectively, and expressed promising in vitro antibiofilm eradication potency. The ultrasound and photoacoustic imaging in infected burn wounds demonstrated improved wound healing reduced inflammation and increased oxygen saturation following treatment with BPs formulations. The obtained results suggested that the incorporation of the BPs in the MP-gel protected the BPs, sustained the BPs release, and improved the antibacterial activity.
金黄色葡萄球菌(S. aureus)和铜绿假单胞菌(P. aeruginosa)是烧伤感染中最常见的细菌。多药耐药(MDR)和生物膜形成使得这些感染难以治疗。噬菌体(BPs)已被证明是治疗 MDR 以及生物膜相关伤口感染的有效方法。在本工作中,开发了一种受自然启发的负载噬菌体的壳聚糖微粒载体制剂 topical gel,用于有效治疗这些感染。分别和联合分离并负载针对 MDR 的金黄色葡萄球菌(BPSAФ1)和铜绿假单胞菌(BPPAФ1)的噬菌体到壳聚糖微粒(BPSAФ1-CHMPs、BPPAФ1-CHMPs 和 MBP-CHMPs)中,随后将其纳入 SEPINEO™ P 600 gel(BPSAФ1-CHMPs-gel、BPPAФ1-CHMPs-gel 和 MBP-CHMPs-gel)中。对 BPs 的形态、裂解活性、爆发大小和血液相容性进行了表征,BPs 属于长尾病毒科。此外,BPSAФ1-CHMPs、BPPAФ1-CHMPs 和 MBP-CHMPs 的平均粒径分别为 1.19±0.11μm、1.42±0.21μm 和 2.84±0.28μm,并且表现出有前景的体外抗生物膜消除能力。在感染性烧伤伤口中的超声和光声成像显示,经 BPs 制剂处理后,伤口愈合得到改善,炎症减轻,氧饱和度增加。结果表明,将 BPs 纳入 MP-gel 中可以保护 BPs,持续释放 BPs,并提高抗菌活性。